Clinical and Translational Medicine (Sep 2020)
A novel miR‐82 target PA2G4 and FHL3 checking myocardial ischemia
- Ruixia Kang,
- Bing Li,
- Yingying Zhang,
- Qiong Liu,
- Jun Liu,
- Yifei Qi,
- Fei Teng,
- Huaiqian Xu,
- Zhenhua Liu,
- Xiaolong Zhu,
- Wangmin Qiao,
- Jinzhou Tian,
- Yimin Wang,
- Jingyi Nan,
- Jian Guo,
- Zhong Wang
Affiliations
- Ruixia Kang
- Institute of Basic Research in Clinical Medicine China Academy of Chinese Medical Sciences Beijing China
- Bing Li
- Institute of Information on Traditional Chinese Medicine China Academy of Chinese Medical Sciences Beijing China
- Yingying Zhang
- Dongzhimen Hospital Beijing University of Chinese Medicine Beijing China
- Qiong Liu
- Institute of Basic Research in Clinical Medicine China Academy of Chinese Medical Sciences Beijing China
- Jun Liu
- Institute of Basic Research in Clinical Medicine China Academy of Chinese Medical Sciences Beijing China
- Yifei Qi
- Institute of Basic Research in Clinical Medicine China Academy of Chinese Medical Sciences Beijing China
- Fei Teng
- Beijing Genomics Institute Shenzhen China
- Huaiqian Xu
- Beijing Genomics Institute Shenzhen China
- Zhenhua Liu
- Beijing Genomics Institute Shenzhen China
- Xiaolong Zhu
- Beijing Genomics Institute Shenzhen China
- Wangmin Qiao
- Beijing Genomics Institute Shenzhen China
- Jinzhou Tian
- Dongzhimen Hospital Beijing University of Chinese Medicine Beijing China
- Yimin Wang
- Shananxi Buchang Pharmaceutical Co., Ltd. Xianyang China
- Jingyi Nan
- Shananxi Buchang Pharmaceutical Co., Ltd. Xianyang China
- Jian Guo
- Shananxi Buchang Pharmaceutical Co., Ltd. Xianyang China
- Zhong Wang
- Institute of Basic Research in Clinical Medicine China Academy of Chinese Medical Sciences Beijing China
- DOI
- https://doi.org/10.1002/ctm2.179
- Journal volume & issue
-
Vol. 10,
no. 5
pp. n/a – n/a
Abstract
No abstracts available.
